• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 Fas 抗原和可溶性 Fas 配体与宫内生长受限。

Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.

机构信息

Second Department of Obstetrics and Gynecology, Athens University Medical School, Athens, Greece.

出版信息

Neonatology. 2010;97(1):31-5. doi: 10.1159/000227290. Epub 2009 Jul 7.

DOI:10.1159/000227290
PMID:19590243
Abstract

BACKGROUND

The Fas-Fas ligand (FasL) pathway of apoptosis contributes to immune tolerance at the fetomaternal interface and has been ascribed a role in implantation and placental development. Intrauterine growth restriction (IUGR) may be associated with impaired maternal-fetal tolerance, resulting in increased trophoblast apoptosis and uteroplacental vascular insufficiency.

OBJECTIVES

To investigate soluble Fas (sFas) and FasL (sFasL) concentrations in maternal, fetal and neonatal serum of IUGR and appropriate-for-gestational-age (AGA) pregnancies.

METHODS

Circulating sFas and sFasL concentrations were determined in 40 mothers and their 20 IUGR (due to several etiologies) and 20 AGA singleton full-term fetuses and neonates on postnatal day 1 (N1) and 4 (N4).

RESULTS

No significant differences in sFas and sFasL concentrations were observed between groups. In both groups, maternal sFas concentrations were increased compared to fetal, N1 and N4 ones (p< or =0.005 in AGA and p < 0.001 in IUGR, in all cases). On the other hand, maternal sFasL concentrations were lower compared to fetal, N1 and N4 ones (p < 0.001 in all cases). Fetal sFasL concentrations were increased compared to maternal, but lower compared to N4 sFasL ones (p < 0.001 in AGA and p < or = 0.020 in IUGR, in all cases). N4 sFasL concentrations were elevated compared to N1 ones (p < 0.001).

CONCLUSIONS

Circulating maternal, as well as fetal sFas and sFasL concentrations do not differ between AGA controls and IUGR cases, irrespectively of the etiology of the latter. Furthermore, the results of this study imply an acceleration of Fas-FasL-mediated apoptosis during delivery and a respective decrease postpartum in both normal and IUGR pregnancies.

摘要

背景

凋亡的 Fas-Fas 配体(FasL)途径有助于胎儿母体界面的免疫耐受,并被认为在植入和胎盘发育中起作用。宫内生长受限(IUGR)可能与母体-胎儿耐受受损有关,导致滋养细胞凋亡增加和胎盘血管功能不全。

目的

研究 Fas 可溶性(sFas)和 FasL(sFasL)在 IUGR 和适合胎龄(AGA)妊娠的母、胎及新生儿血清中的浓度。

方法

在产后第 1 天(N1)和第 4 天(N4),检测 40 名母亲及其 20 名 IUGR(由于多种病因)和 20 名 AGA 单胎足月胎儿和新生儿的循环 sFas 和 sFasL 浓度。

结果

两组间 sFas 和 sFasL 浓度无显著差异。在两组中,与胎儿、N1 和 N4 相比,母体 sFas 浓度均升高(AGA 中均 p<0.005,IUGR 中均 p<0.001)。另一方面,与胎儿、N1 和 N4 相比,母体 sFasL 浓度均较低(所有病例均 p<0.001)。胎儿 sFasL 浓度高于母体,但低于 N4 sFasL 浓度(AGA 中均 p<0.001,IUGR 中均 p<0.020)。N4 sFasL 浓度高于 N1(p<0.001)。

结论

AGA 对照组和 IUGR 病例组之间,循环母体、胎儿 sFas 和 sFasL 浓度无差异,与后者的病因无关。此外,本研究结果表明,在分娩过程中 Fas-FasL 介导的凋亡加速,产后相应减少,在正常和 IUGR 妊娠中均如此。

相似文献

1
Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.可溶性 Fas 抗原和可溶性 Fas 配体与宫内生长受限。
Neonatology. 2010;97(1):31-5. doi: 10.1159/000227290. Epub 2009 Jul 7.
2
Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.足月围产期循环骨保护素和可溶性核因子κB受体活化因子配体(sRANKL)浓度。宫内生长受限的影响。
Neonatology. 2009;96(2):132-6. doi: 10.1159/000211666. Epub 2009 Apr 8.
3
Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.足月妊娠围产期骨转换:宫内生长受限的影响。
Bone. 2008 Feb;42(2):307-13. doi: 10.1016/j.bone.2007.10.002. Epub 2007 Oct 16.
4
Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.网膜素-1 和内脂素存在于胎儿和新生儿中,正常妊娠和生长受限妊娠的围产儿浓度相似。
Metabolism. 2011 Apr;60(4):486-90. doi: 10.1016/j.metabol.2010.04.014. Epub 2010 May 20.
5
Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.宫内生长受限胎儿和新生儿中的可溶性血管内皮生长因子受体-1
Early Hum Dev. 2006 Apr;82(4):235-9. doi: 10.1016/j.earlhumdev.2005.09.010. Epub 2005 Dec 5.
6
Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.子痫前期合并胎儿生长受限孕妇母血及脐静脉血血清sFas/sFasL系统的评估
Eur J Obstet Gynecol Reprod Biol. 2006 Jun 1;126(2):155-9. doi: 10.1016/j.ejogrb.2005.08.015. Epub 2005 Sep 19.
7
Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.正常及胎儿生长受限的人类妊娠中的血清胎球蛋白-A/α2-HS-糖蛋白
J Matern Fetal Neonatal Med. 2008 Nov;21(11):826-30. doi: 10.1080/14767050802326255.
8
Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.宫内生长受限可能不会抑制足月时的骨形成,这可通过循环中未羧化骨钙素和 Dickkopf-1 的浓度来指示。
Metabolism. 2012 Mar;61(3):335-40. doi: 10.1016/j.metabol.2011.07.008. Epub 2011 Sep 23.
9
Serum cystatin C in pregnancies with normal and restricted fetal growth.胎儿生长正常和受限的妊娠中的血清胱抑素C
Reprod Sci. 2007 Jan;14(1):37-42. doi: 10.1177/1933719106298196.
10
Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.正常和受限胎儿生长的妊娠中血浆抵抗素浓度的围产期变化
Neonatology. 2008;93(3):153-7. doi: 10.1159/000108412. Epub 2007 Sep 18.

引用本文的文献

1
Neonatal and Long-Term Consequences of Fetal Growth Restriction.胎儿生长受限的新生儿及长期后果
Curr Pediatr Rev. 2018;14(4):212-218. doi: 10.2174/1573396314666180712114531.
2
Clinical and biochemical effects of environmental tobacco smoking on pregnancy outcome.环境烟草烟雾对妊娠结局的临床和生化影响。
Indian J Clin Biochem. 2013 Oct;28(4):368-73. doi: 10.1007/s12291-012-0267-y. Epub 2012 Oct 2.